INTELLIGENCE IN ACTION

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

August 01, 2018

The need for greater price transparency in healthcare is all over the news. Policy makers across the country have taken up the cause. Patients are demanding real change, as healthcare costs continue to rise and hit pocketbooks hard. Given that Surescripts processes nearly 5 million electronic prescriptions each day, we’re focused on leveraging technology to improve prescription price transparency specifically. Americans spent $425 billion on prescriptions in 2015, a more than 12 percent increase from 2014. And the nation’s spending on medicines is forecasted to reach $610-640 billion in 2020.

In a recent Becker’s Healthcare podcast, Surescripts Chief Executive Officer Tom Skelton talked about how the Surescripts Network Alliance is taking prescription price transparency from hot topic to healthcare reality. He also talked about why.

“We’re trying to step back and look at things more holistically to ensure we’re addressing issues that may be impacting medication adherence,” Skelton said. “We know that ten percent of people who abandon their prescriptions do so because of cost. We also have data that shows that about 40 percent of patients will abandon treatment when a prior authorization is required.”

Tom Skelton | Becker's Hospital Review

For more perspective on the criticality of price transparency, interoperability and more, check out the article and podcast

Related Articles

January 15, 2020

How One to Two Seconds Can Improve Patient and Physician Lives

As a physician, I’m very familiar with this scenario. You see a patient and prescribe a medication. They show up at the pharmacy to pick it up only to learn they can’t afford it. The pharmacist calls you for an alternative. And you have to revisit the patient chart hours, sometimes days, after they’ve left your office, starting the whole process over again.

Read more...
December 04, 2019

Forces of Change: The Industry Responds to the Call for Prescription Price Transparency

As reported in our 2019 Impact Report: Prescription Price Transparency, the number of prescribers using our Real-Time Prescription Benefit solution more than doubled in 2019, from roughly 100,000 in January to nearly 250,000 prescribers in November.

Read more...
November 06, 2019

Record-Breaking FDA Approvals Mean Hope for Patients but Challenges for Healthcare Access, Delivery and Affordability

Last year, the U.S. Food and Drug Administration (FDA) approved a record-breaking 59 new medicines that will advance healthcare for patients with chronic and rare diseases.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX